Hypoxia at Multiple Wavelengths of Light
Completed
- Conditions
- Hypoxia in Healthy Individuals
- Registration Number
- NCT01957891
- Lead Sponsor
- Nonin Medical, Inc
- Brief Summary
The purpose of the study is to assess the effect of progressive, incremental hypoxia at multiple wavelengths of light.
- Detailed Description
No additional information is required.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 26
Inclusion Criteria
- Is between 18 and 35 years of age
- Is American Society Anesthesiologist status 1
- Has a BMI between 18 and 30
Exclusion Criteria
- Currently taking any medications other than birth control pills
- Has participate in an investigational drug study within one month prior to the start of the study
- Fails the Allen's Test to confirm patency of the colateral artery
- Subject is female with a positive pregnancy test, or is female and is unwilling to use effective birth control between the time of screening and study termination
- Has a positive urine continine or drug test
- Has an reported allergy to Lidocaine
- Has anemia or other hemoglobinopathy
- Has a room air saturation less than 95% by pulse oximetry
- Has an abnormal EKG
- Has an abnormal pulmonary function test via spirometry
- Is intolerant to a breathing mask apparatus
- Has a COHb greater than 3%, or MetHb greater than 2%
- Has another condition, which in the opinion of the principle investigator would not be suitable for participation in the study
- Is unwilling or unable to provide informed consent or comply with the study procedures
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assess the effect of progressive, incremental hypoxia at multiple wavelengths of light Up to 8 weeks
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
HPPL Duke Univeristy
🇺🇸Durham, North Carolina, United States